Non-Invasive Model for Fibrosis Regression in HBV Patients

RecruitingOBSERVATIONAL

Enrollment

1,100

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

May 1, 2026

Conditions

Chronic Hepatitis B Virus (HBV) InfectionLiver Fibrosis

Interventions

DRUG

Nucleos(t)ide Analogs (NA)

all patients received NAs

Trial Locations (1)

RECRUITING

Beijing Friendship Hospital, Beijing

All Listed Sponsors

lead

Beijing Friendship Hospital

OTHER